Fakultni Nemocnice Plzen

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)1 trial
• Hidradenitis suppurativa1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Amgen Inc.1 trial
• Boehringer Ingelheim1 trial

Closed trials

• Completed

  A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon)

  2022-501538-44-00· Phase 3· Amgen Inc.· Source

• Completed

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· Phase 2/3· Boehringer Ingelheim· Source